Mithra Pharmaceuticals SA MITRA-BE:Euronext Brussels

*Data is delayed | EUR
Last | 05/07/21 CEST
23.70quote price arrow up+0.90 (+3.95%)
Volume
75,149
52 week range
14.92 - 28.95

...

Loading . . .
  • Open22.80
  • Day High23.90
  • Day Low22.50
  • Prev Close22.80
  • 52 Week High28.95
  • 52 Week High Date03/31/21
  • 52 Week Low14.92
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap1,227.06M
  • Shares Out42.71M
  • 10 Day Average Volume77,178.18
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change20.3

KEY STATS

  • Open22.80
  • Day High23.90
  • Day Low22.50
  • Prev Close22.80
  • 52 Week High28.95
  • 52 Week High Date03/31/21
  • 52 Week Low14.92
  • 52 Week Low Date10/30/20
  • Market Cap1,227.06M
  • Shares Out42.71M
  • 10 Day Average Volume77,178.18
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change20.3

RATIOS/PROFITABILITY

  • EPS (TTM)-2.23
  • P/E (TTM)-10.62
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mithra Pharmaceuticals SA

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Mithra Pharmaceuticals SA is a Belgian-based company active in the pharmaceutical industry. The Company is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The Company provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a...
Marc Coucke
Non-Executive Chairman
Leon Van Rompay
Chief Executive Officer
Christophe Marechal
Chief Financial Officer
Jean-Manuel Fontaine
Vice President
Address
Rue Saint-Georges 5
Liege
4000
Belgium